Zydus Lifesciences buyback at Rs 1,260 per share, size up to Rs 1,100 cr
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts less than Nifty 100 and 0.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Zydus Lifesciences will buy back up to 87.30 lakh shares (0.87 percent of paid-up capital) at Rs 1,260 per share, for an aggregate size of up to Rs 1,100 crore. The offer price was revised upward from the original Rs 1,150. Buyback will be on a proportionate basis through the tender offer route. Record date is May 29, 2026. The buyback window runs from June 4 to June 10, 2026. Small shareholders can tender 5 shares for every 49 held; general category shareholders can tender 7 for every 937 held.
Eligible shareholders can tender shares at Rs 1,260 each. Buyback signals confidence in valuation and may support the stock price in the near term.